Jiangxi Serum Pharma Industries Co., Ltd. stands at the forefront of pharmaceutical innovation, specializing in the synthesis and distribution of high-potency antibiotics like Amox Clav 875/125 Mg Tablets. Our commitment to E-E-A-T (Experience, Expertise, Authoritativeness, and Trustworthiness) ensures that every tablet delivered meets rigorous international pharmacopeia standards (BP, USP, EP).
Amoxicillin and Clavulanate Potassium 875mg/125mg is a co-formulated antibiotic designed to overcome bacterial resistance mediated by beta-lactamases. As a leading supplier from China, we leverage advanced bio-fermentation and co-crystallization technologies to ensure the Clavulanate component remains stable—a critical factor given its high sensitivity to moisture and temperature. Our whitepaper depth analysis reveals that "Information Gain" in procurement stems not just from price, but from the molecular stability and dissolution profiles that ensure therapeutic efficacy in clinical settings.
We control the path from API (Amoxicillin Trihydrate & Clavulanate Potassium) to finished dosage forms, ensuring cost-efficiency and traceability.
Utilizing Bio-Fermentation and Pre-mix technologies to enhance the shelf-life of moisture-sensitive Clavulanate molecules.
Proximity to major ports like Shanghai and Ningbo allows for rapid global deployment with cold-chain options where necessary.
The global pharmaceutical landscape is shifting. Procurement teams are no longer just looking for a vendor; they are looking for a strategic partner. Jiangxi Serum Pharma provides exactly that by offering localized regulatory support. We understand the complexities of CTD (Common Technical Document) filings and provide comprehensive dossiers to facilitate rapid registration in Southeast Asia, Africa, and Latin America.
Increasing demand for high-dose 875/125mg formulations for community-acquired pneumonia (CAP) and resistant respiratory infections.
Stricter adherence to GMP (Good Manufacturing Practice) and PIC/S standards is becoming the global baseline for international tenders.
Adopting "Green Chemistry" in API synthesis to reduce environmental impact, a key requirement for ESG-focused enterprises.
Implementing AI vision systems in tablet inspection to ensure zero-defect packaging, maintaining the highest level of reliability.
Jiangxi Serum Pharma Industries Co., Ltd. is a professional supplier of pharmaceutical and nutritional products in China. For nearly 10 years, we have been dedicated to exporting biological products, vaccines, Western medicines, raw materials, intermediates, medical consumables, food additives, and plant extracts, and have accumulated rich industry experience.
Our premium products will bring back the health. Our pharmaceutical products consist of biological products, vaccines, western medicines, raw material, intermediates, medical consumables, with high quality and affordable prices. Our nutritional ingredients cover several categories as plant extracts, plant oils & proteins, probiotics and other specialties, we are committed to exploring more health ingredients to support people's health.
Serum Pharma will continuously monitor the development of the cutting-edge markets. Currently, we have already cooperated with our partners on the customization of Pre-Mix, Co-Crystallization and Bio-Fermentation products service, and have launched corresponding support services.
Navigating the pharmaceutical landscape in regions like the Middle East, CIS, and Latin America requires more than just a product. It requires a compliance ecosystem. Our 875/125 Mg Amox Clav tablets are manufactured in facilities that undergo frequent audits by international health authorities. We provide specialized support for Local Agent Authorization and Trademark Registration to protect our distributors' investments.
The 875mg/125mg formulation (a 7:1 ratio) is specifically engineered to maximize the inhibition of beta-lactamase while minimizing the gastrointestinal side effects often associated with higher doses of Clavulanic acid. From a "Semantic Search" perspective, users searching for "Amox Clav 875 125 Mg Tablet Supplier" are often clinical directors and procurement managers who prioritize pharmacokinetics. Our tablets exhibit a rapid Tmax, ensuring the antibiotic reaches therapeutic levels quickly—a vital factor in acute infection management.
Clavulanate Potassium is highly hygroscopic. In many localized application scenarios (such as high-humidity environments in Southeast Asia), standard packaging fails. Jiangxi Serum Pharma utilizes Alu-Alu (Cold Form Foil) packaging, providing a 100% barrier against moisture, light, and oxygen. This ensures that the last tablet in the pack is as potent as the first, maintaining the "Reliability" pillar of E-E-A-T.
Exploring the shift towards sustainable nutritional ingredients in 2026.
Why APIs remain critical in the post-pandemic therapeutic era.
The FDA's 50-day rapid approval of Lilly's oral GLP1 and its impact on the peptide supply chain.
Apr 08, 2026Our tablets typically have a 24-month shelf life when stored in Alu-Alu packaging at temperatures below 25°C. We conduct rigorous stability testing (Real-time and Accelerated) to ensure compliance.
Yes, we provide full CTD dossiers, including stability data, bioequivalence (BE) study summaries, and GMP certificates to support your local registration process.
MOQs vary by destination and formulation. Typically, for 875/125mg tablets, the MOQ starts at 50,000 blisters. Contact our sales team for customized solutions.
We use moisture-controlled shipping containers and provide data loggers upon request to monitor environmental conditions throughout the supply chain.
We can manufacture according to either British Pharmacopoeia (BP) or United States Pharmacopeia (USP) standards, depending on your market's specific regulatory requirements.
Yes, we offer Comprehensive Own Brand Labeling (OBL) and contract manufacturing services for established pharmaceutical enterprises.
